vimarsana.com

பல்கலைக்கழகம் ஆஃப் மான்செஸ்டர் உலகளாவிய வளர்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID vaccine weekly: support builds for patent waiver as shortages threaten to bite

The US has this week backed a proposal to allow countries to manufacture COVID-19 vaccine doses without needing the agreement of the vaccines’ rights holders. This would be enabled by temporarily waiving intellectual property (IP) protection on all COVID-19 medical products. Removing such protections, the waiver’s proponents argue, will increase the amount of vaccine doses produced globally. This is the theory. But in practice, waiving IP is unlikely to be a short-term solution to increasing vaccine manufacture, argues Anne Moore, senior lecturer in biochemistry and cell biology at University College Cork. Skills, knowledge and equipment will need to be shared and developed at new sites, which takes time, and material shortages are already limiting production.

Indian women experience far more Covid-related hardship than men, research finds

Irrigation schemes in sub-Saharan Africa are consistently falling short of their promises

Date Time Irrigation schemes in sub-Saharan Africa are consistently falling short of their promises Irrigation schemes in sub-Saharan Africa don’t measure up to their plans according to new research into the projects by scientists. Many of the schemes were found to be consistently delivering a much smaller area of irrigation or are completely broken and things aren’t improving. Large-scale irrigation infrastructure projects are back on the development agenda in sub-Saharan Africa after a near 30-year hiatus, despite projects having had disappointing results, with social and environmental side effects outweighing benefits. Such projects are planned in response to water scarcity pressures and are seen as a solution to intensify agricultural production, support rural economic development and enhance resilience to climate change.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.